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Abstract 
A total of 66 samples of seafood were tested for the presence of Listeria monocytogenes and other 
Listeria species. Listeria spp. were present in 23% of the samples (15/66) of them, 10 isolates were 
characterized as L. innocua (66.67%), 2 L. monocytogenes (13.33%), 1 L. grayi (6.67%), 1 L. seeligeri (6.67%) 
and 1 L. ivanovii (6.67%). Of the total bacterial isolates, the 20% (3/15) showed ability to form biofilm, 
identified as 2 species of L. innocua and 1 L. monocytogenes.  
The anti-Listeria activity of aqueous extracts of A. caven, A. furcatispina, P. torquata and N. cataria 
and their combinations was determined. The aqueous extract of P. torquata and N. cataria showed the 
highest inhibitory activity against strains of Listeria (2.5 mg/mL and 5 mg/mL respectively). The 
antibacterial activity was enhanced by the mixture of some extracts. The combinations of A. caven + A. 
furcatispina and A. furcatispina + P. torquata showed beneficial effect to inhibit the growth of Listeria. 
The fractional inhibitory concentration (FIC) index for this mixture indicated an additive effect (FIC = 
0.75 and 0.56 respectively), while the remaining combinations showed indifferent effect. However, 
none of natural products, as well as all mixtures showed inhibitory activity in biofilm formation by 
Listeria at least, under the conditions assayed. 
Keywords: anti-Listeria activity, Acacia spp, biofilm, combinations of natural products, Nepeta cataria, 
Prosopis torquata  
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Introduction 
Since ancient times, plants are used as alternative 
medicine for the extensive properties they own. 
Plants have been a valuable source of natural 
products for maintaining human health. The 
antimicrobial properties of plants have been 
investigated by a number of researchers worldwide, 
especially in Latin America. In Argentina, a research 
tested 122 known plant species used for therapeutic 
treatments (1). 
Currently, food safety remains a topic of great 
interest to public health, even if they have improved 
and modernized hygiene practices in refrigerators 
and food production techniques. It is estimated that 
in industrialized countries, about 30% of the 
population suffers every year, food borne illness. 
Therefore, there remains a need for new methods 
to reduce or eliminate food borne pathogens, 
possibly in combination with existing. In addition, 
the ability to form biofilms on different surfaces, 
contributes to the biofilm-producing bacteria are 
one of the major concerns for the food industry (2, 
3, 4). In this sense, new strategies are designed to 
eradicate biofilms and are increasing the use of 
substances with natural active ingredients.  
Listeria monocytogenes is responsible for 
producing listeriosis, a fatal disease it is most 
prevalent in immune-compromised individuals. The 
increase in numbers of immune-compromised 
individuals against a background of Listeria 
antibiotic resistance, limits listeriosis treatment 
options. This therefore calls for research into 
substitute treatments, of which, medicinal plants 
derived compounds offer a viable alternative. 
The genus Listeria comprises fifteen species but 
only two are considered pathogenic (5). L. ivanoii is 
pathogenic for animals like cattle and small 
ruminants, while L. monocytogenes is pathogenic for 
both animals and humans (6, 7). L. monocytogenes is 
a gram-positive, intracellular facultative anaerobic 
bacillus, with optimum growth range of 30-37 °C but 
can grow at refrigerator temperatures. This species 
is cause listeriosis, which can produce 
gastroenteritis, septicemia, perinatal infections, 
fetal death, abortion, meningitis and 
meningoencephalitis in immunocompromised 
individuals (8, 9). 
Contaminated foods such as raw vegetables, 
meats and ready to eat foods are the major source 
of pathogenic Listeria, such that the gastrointestinal 
tract is the bacteria’s primary site of entry (10). 
This disease occurs with a high mortality rate 
worldwide, ranging between 20% and 30%, reaching 
up to 80% in cases of neonatal infections (11). L. 
monocytogenes is widely distributed in the 
environment so that man is exposed to the bacteria 
in several ways. Approximately 99% of human 
listeriosis infections appear to be food borne (12). It 
has been isolated from various foods, especially 
those raw and ready-to-eat foods, cabbage, 
pasteurized milk, cheese, vegetables, raw fish and 
seafood (13).  
Within virulence factors, it is their potential ability 
to produce biofilms, both biotic surfaces (plants, 
tissues) and abiotic (stainless steel, plastic) (14). This 
ability to adhere to the surfaces of industrial 
facilities leads to serious health problems and 
economic losses. The biofilm serves as a reservoir 
for continuous release of bacteria processed foods 
in contact with those surfaces, as it is found that 
adherent bacteria are more resistant to the 
processes of cleaning and sanitizing allowing 
survival for long periods of storage and difficult to 
eradicate (15). Currently, food safety remains a topic 
of great interest to public health, even if they have 
improved and modernized hygiene practices in 
refrigerators and food production techniques. It is 
estimated that in industrialized countries, about 30% 
of the population suffers every year, food borne 
illness. Therefore, there remains a need for new 
methods to reduce or eliminate food borne 
pathogens, possibly in combination with existing. In 
addition, the ability to form biofilms on different 
surfaces, contributes to these bacteria are one of 
the major concerns for the food industry (2, 3, 4). In 
fact, biofilms, densely packed communities of 
microbial cells growing in a living or inert surface 
and surrounded by a self-produced polymeric 
matrix, requires much higher doses of antibiotics 
(10–1000 times) for bacterial killing and can lead to 
chronic and persistent infections (16). This occurs 
because biofilm protects bacteria against several 
physicochemical aggressions, including ultraviolet 
light, heavy metals, acidity, modulation in hydration 
or salinity, and phagocytosis (17). In this sense, new 
strategies are designed to eradicate biofilms and are 
increasing the use of substances with natural active 
ingredients (18). Hence, more studies pertaining to 
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the use of plants as therapeutic agents for their 
application both in clinical medicine and in the food 
industry should be emphasized. Vegetable extracts 
from various plants native to Argentina, such as 
Acacia caven, Acacia furcatispina, Prosopis torquata 
and Nepeta cataria have been used by people to 
treat diseases as a form of folkloric medicine. The 
aims of this study were to investigate the ability of 
biofilm production of Listeria strains isolated from 
frozen raw seafood and to evaluate the anti-Listeria 
effect of the plants extracts mentioned before 
alone and combined and their effect on biofilm-
grown.  
Methods 
Samples and isolates bacterial   
Sixty six samples of seafood were analyzed. From 
frozen raw seafood such as are sold commercially, 
10 g of each sample was weighed and incubated in 
Palcam broth 24 h at 37º (pre-enrichment) and then, 
subcultured in Palcam agar and incubated 48 h at 
37ºC. If growth is not detected in Palcam agar, 
isolating was retried from cold selective enrichment 
in Palcam broth for 7 days at 4ºC. Suspicious 
colonies of Listeria spp were recognized for being 
small, black, and greenish, with depressed center 
and blackening of the medium. These colonies were 
inoculated in trypticase soy agar (TSA) and 
incubated 24 h at 37ºC. Identification of Listeria spp 
was carried out using the standard biochemical tests 
including Gram staining, motility test fresh, catalase, 
hemolysis on horse blood agar and sugar 
fermentation (19). These bacterial isolates together 
with reference strains Collection Microbiology 
Laboratory strains were used in subsequent assays. 
Bacterial strains were maintained in Lauria Bertani 
broth (LB) containing 20% glycerol at -80°C until use. 
Plants aqueous extracts 
Aqueous extracts (decoctions) from aerial parts 
of Acacia caven var. caven DC (A), Acacia 
furcatispina (B) and Prosopis torquata Cav. Ex. Lag 
DC (C) were prepared as previously described 
Martinez et al, 2014 (20). Aqueous extract of N. 
cataria (D) previously obtained by Arce et al was 
also used in this study (21). They were sterilized by 
membrane filtration of 0.20 μm cellulose and stored 
at -20 °C until use. The 1:1 combinations of A+B, A+C, 
A+D, B+C, B+D and C+D were also assayed. 
Antibacterial activity: Determination of minimal 
inhibitory concentration (MIC)  
The MICs of extracts A, B, C and D were 
determined by microplate method (micro-well 
dilution) according to CLSI method (22), in tripticase 
soy broth (TSB) (Britania, Argentina) pH 7.2 
supplemented with 0.01% (W/V) of 2,3,5-
triphenyltetrazolium chloride as visual indicator of 
bacterial growth. A starting concentration of 
40 mg/ml of each aqueous extract dissolved in 1% 
DMSO was serially diluted double fold in TSB to 
make different test concentrations of the 
compounds in the wells. The 96-well plates were 
prepared by dispensing into each well 95 µL of 
nutrient broth and 5 µL of the inoculum (106 
CFU/mL). One hundred microlitres aliquot from the 
stock solutions of the extracts and their serial 
dilutions initially prepared were transferred into 
eight consecutive wells. The final volume in each 
well was 200 µL. Controls of nutrient broth, strains 
and extracts were also included in the experiment. 
The 1% DMSO was also tested for its possible anti-
Listeria activities. The plates were incubated at 37°C 
for 24 h. A colour change (viewing with the naked 
eye) from colourless to red, indicated actively 
growing bacteria. MIC was defined as the lowest 
concentration of the extracts in the medium in 
which there was no visible growth. Assays were 
performed in duplicate and then replicated at least 
twice.  
Determination of minimal bactericidal 
concentration (MBC)  
The aqueous extracts that showed inhibitory 
activity in the preliminary broth assay were 
submitted to a subculture on the surface of the TSA 
plates, in order to evaluate bacterial growth. MBC 
was interpreted as the minimum concentration of 
the antibacterial agent that prevented the growth 
of viable colonies on the tripticase soy agar after 24 
h of aerobic incubation at 37° C. Assays were 
performed in duplicate and then replicated at least 
twice.  
Determination of the antibacterial activity of 
combined extracts 
The 1:1 combinations of A+B, A+C, A+D, B+C, B+D 
and C+D were assayed. In each initial combination, 
the concentration of each individual extract was 20 
mg/mL. Then, serial two-fold dilutions were made in 
concentration ranges from 20 mg/mL to 0.625 
mg/mL. The 96-well plates were prepared by 
dispensing into each well 95 µL of nutrient broth, 5 
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µL of the inocula and 100µL of extracts mixture 
and their serial dilutions initially prepared. The final 
volume in each well was 200 µL. Controls of nutrient 
broth, strains and extracts were also included in the 
experiment. The plates were incubated at 37°C for 
24 h. Assays were performed in duplicate and then 
replicated at least twice. MIC values were 
determined for each of these combinations to 
establish any interaction effect. The MIC of mixture 
was compared with MICs of each extract separately 
to obtain the fractional inhibitory concentration 
(FIC) index (23). The FIC index of extract A (FICA)  
and extract B was calculated as the ratio of the MIC 
value of the extract in combination (A + B) over the 
MIC value of the extract alone (A or B). The overall 
FIC index (ΣFIC) was calculated as the summation of 
the FICA and the FICB. The interactions were 
interpreted as synergism when the ΣFIC index≤0.5, 
additive when 0.5<ΣFIC index≤1, and indifference 
when 1<ΣFIC index<4 whilst antagonism was defined 
as when the ΣFIC index is ≥4. 
Quantitative determination of biofilm production 
   Biofilm production was carried out as described 
previously (24). Briefly, in each well 150 μL of TSB 
supplemented with 1% glucose and 50 μL of 
inoculums Listeria spp (108 CFU/mL) were 
inoculated into 96-well U bottom polystyrene 
microtiter plates and incubated at 37 ° C for 72 h. The 
wells were washed 3 times with phosphate buffered 
saline (PBS, pH 7.2), air dried and stained with 1% 
crystal violet solution for 15 min and then, fixed with 
methanol (200 μL) for 15 min. The unbonded dye 
was removed and washed with distilled water. The 
plate was allowed to dry air for 24 h. The content of 
the wells was resuspended with ethanol and was 
transferred to a flat bottom plate. The optical 
density (OD) the wells was measured at 550 nm 
using ELISA reader (Microplate Reader Benchmark, 
BIO-RAD). For classification of isolates according to 
their ability to form biofilms, a cut-off value was 
obtained (ODc =0.300). Values above or below this 
point determined producing or non-producing 
biofilm strains respectively.  
Positive and negative controls strains were used 
as was a negative control of medium. Positive 
biofilm S. aureus strain 11F2, positive biofilm L. 
monocytogenes CLIP 74904 and negative biofilm S. 
epidermidis ATCC 12228 were included as controls. 
The tests were carried out in quadruplicate and 
were replicated at least twice, and the averages and 
standard deviations were calculated for all 
repetitions of the experiments.  
Determination of anti-biofilm activity of extracts of 
plants and their combinations 
The aqueous extracts of A. caven (A), A. 
furcatispina (B), P. torquata (C) and N. cataria (D) 
and the combinations (1:1) of A+B, A+C, A+D, B+C, 
B+D and C+D at their MIC value were tested for their 
ability to interfere with the biofilm production by 4 
strains of Listeria and 4 strains of S. aureus. An 
aliquot of 50 μL of each bacterial suspension (108 
CFU/mL), 50 μL of TSB supplemented with 1% 
glucose and 100 μL of extracts or mixture were 
placed into each well of 96-well plates. After 72h 
incubation at 37° C, the content was aspirated and 
the plates were washed with PBS, dried, fixed with 
methanol and stained with 1% crystal violet solution 
in water for 15 min. The content adhered was 
resuspended in 200 µL of ethanol and read in ELISA 
reader. OD550 ≥ 0.300 was considered producing 
biofilm. The tests were carried out in quadruplicate 
and were replicated at least twice, and the averages 
and standard deviations were calculated for all 
repetitions of the experiments. 
Results and Discussion   
Fifteen (15/66) isolates of Listeria were collected 
from seafood samples (23%), of them, 10 isolates 
were characterized as L. innocua (66.67%), 2 L. 
monocytogenes (13.33%), 1 L. grayi (6.67%), 1 L. 
seeligeri (6.67%) and 1 L. ivanovii (6.67%). All bacterial 
isolates were genetically confirmed at the Pasteur 
Institute Center Listeria, Francia. 
The presence of Listeria species in raw frozen 
shellfish warns about the importance of proper 
cooking of these foods before ingestion and the 
feasibility of these organisms to generate cross 
contamination in seafood processing plant 
environments found higher percentages of L. 
monocytogenes (60%) and L. innocua (30%) (25). 
Conversely, Rozman et al, 2016, only found L. 
innocua (15%) and L. monocytogenes was not 
identified in any of the examined samples of fish and 
fishery products (26). 
The microbiological risk for food consumption is 
one of the main ones reasons for concern for Public 
Health Organizations and the food sector. In this 
field, L. monocytogenes, is an important concern for 
the meat sector and, in particular, for productive
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 and product marketing companies meat ready 
for consumption (RFC). At present, there is a debate 
on the policies of regulation of this pathogen that 
apply in different countries of the world and that 
affect product marketing traditional meat. In the 
international guidelines of Codex Alimentarius and 
online with food security policy at community level 
(Regulation (EC) 2073/2005) or extra-community 
(Canada), different microbiological criteria are 
established based on two risk factors: the 
susceptibility of the population to which food is 
destined and the possibility that food favors or does 
not increase the pathogen during its useful life. 
   In the European Union (EU), a maximum of 100 
cfu/g is established during the life of products not 
intended for the population of risk (children, elderly, 
pregnant women or immunodeprimised), regardless 
of whether the pathogen may or may not grow in 
RFC products. On the other hand, country legislation 
as the United States and Japan at the beginning 
were very restrictive, since established a policy of 
"zero tolerance" (absence in 25g) in front of this 
pathogen, demanding it both in RFC foods and in 
the production environment. However, these 
countries have expanded their regulations, using 
only the "zero tolerance" criteria for RFC products 
where Listeria is able to grow. 
Our results, as well as numerous investigations, 
demonstrate the presence of Listeria species in fish, 
seafood or in sea food processing plants (27, 28, 29). 
These findings are indicators of the importance of 
standardized sanitation procedures to reduce risks 
regarding to this emerging pathogen of significant 
impact on public health. 
Evaluation of anti-Listeria effect 
   The aqueous extracts of A. caven, A. furcatispina, P. 
torquata, N. cataria and their combinations showed 
anti-Listeria activity. The values of MIC varying from 
20 to 2.5 mg/mL (Table 1). The aqueous extract of P. 
torquata and N. cataria showed the greatest 
inhibitory activity against strains of Listeria (2.5 
mg/mL and 5 mg/mL respectively) and the least 
active was A. furcatispina (20 mg/ml). Aqueous and 
ethanolic extracts of both species of Acacia and P. 
torquata in previous studies (20) showed MIC values 
of 2 and 4 mg/mL against other Gram-positive 
bacteria (Staphylococcus aureus). In general, values 
of MIC were bacteriostatic. The 1% DMSO was found 
not to exhibit anti-Listeria activities in-vitro. Higher 
concentrations (one or two fold higher than the 
corresponding MICs values) of decoctions were 
needed to have bactericidal effect.  
   Previous phytochemical study of the A. caven, A. 
furcatispina and P. torquata revealed the presence 
of carbohydrates, tannins, flavonoids, saponins and 
alkaloids either in both aqueous and ethanol 
extracts or in any of them. TLC analysis revealed the 
presence of flavonoids: quercetin (Rf of 0.91) and 
sapogenines: oleanolic acid (Rf of 0.87) (20). 
Nepetalactone compounds mainly found in the 
essential oils of the Nepeta species are considered 
to be responsible for the pharmacological 
properties (30). 
   Recently, plant antimicrobials have been found to 
be synergistic enhancers in that though they may 
not have any antimicrobial properties alone, but 
when they are taken concurrently with standard 
drugs they enhance the effect of that drug (31, 32). 
   There are some generally accepted mechanisms of 
this interaction, including inhibition of protective 
enzymes, combination of membrane active agents, 
sequential inhibition of common biochemical 
pathways, and the use of membranotropic agents 
to enhance the diffusion of other antimicrobials 
(33). 
   Phytotherapy has many potentially significant 
advantages associated with the synergistic 
interactions like, increased efficiency, reduction of 
undesirable effects, increase in the stability or 
bioavailability of the free agents and obtaining an 
adequate therapeutic effect with relatively small 
doses, when compared with a synthetic medication 
(34). 
   Interactions between plant extracts is a novel 
concept and could be beneficial (synergistic or 
additive interaction) or deleterious (antagonistic or 
toxic this outcome). In our study, the combinations 
of A. caven + A. furcatispina and A. furcatispina + P. 
torquata showed beneficial effect for Listeria. The 
MIC data of the mixtures are presented in Table 2. 
The FIC index for this mixture indicated an additive 
effect (0.5<ΣFIC index≤1), while the remaining 
combinations showed indifferent effect (Table 2). 
   All the mixture tested showed bactericidal effect 
against Listeria strain at a maximum concentration 
of 1× MIC or 2× MIC value of the tested extract. 
   An additive interaction is the effect where the 
combined action is equivalent to the sum of the 
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activities of each drug when used alone (35). The 
other combinations tested showed no effect 
synergistic, or additive, or indifferent or 
antagonistic. The decrease in one or two dilution 
steps above the MIC values observed in this work 
can be considered only as partial synergism (36). 
The additive effect of A. caven + A. furcatispina and 
A. furcatispina + P. torquata observed herein, 
probably, suggests the therapeutic applicability of 
such extracts in combination therapy. However, it is 
hard to predict combined effects in vivo on the basis 
of the presented in vitro evidence alone. It must be 
studied in animal models to determine their efficacy 
in vivo, and to elucidate their mechanisms of action.  
   A. caven and A. furcatispina showed good 
inhibitory activity on the growth of Listeria species. 
The mixture or combination of both Acacia species 
had an additive effect on their bacteriostatic 
activity. In addition, these plants do not have 
toxicity. A previous study of our research group 
determined that these species are not genotoxic 
below 10 mg/mL concentration (37). Another 
species of the genus Acacia, A. aroma, was 
previously tested and also had a 
bacteriostatic/bactericidal effect and showed no 
cytotoxic and genotoxic activity (38). Therefore, the 
use of the mixture of both Acacia species represents 
a potential natural product for safe use in 
phytotherapy.  
In contrast, P. torquata showed very good 
antibacterial activity both alone and combined with 
A. furcatispina but was genotoxic at concentrations 
of 0.2 mg/mL (37). Consequently, our next objective 
is to obtain greater bioactivity through chemical 
modifications that reduce toxicity of Prosopis.  
Biofilm production 
   L. monocytogenes is able to form biofilm on several 
surfaces used in the food industry, representing a 
serious concern for food safety because it could 
serve as source of contamination. In fact, L. 
monocytogenes has been isolated from a wide range 
of processed foods (39, 40, 41) and also cooked 
food can be contaminated as the results of post-
process contamination (42). Microtitre assay is an 
effective method to identify biofilm forming species. 
This method allowed to identify 3 Listeria isolates 
producing biofilm characterized as L. innocua (13%, 
2/15) and L. monocytogenes (7%, 1/15) (Table 3, Fig. 1). 
The species L. grayi, L. ivanovii and L. seeligeri were 
no producer biofilm (OD<0.300).   
Evaluation of anti-biofilm effect 
   Given the potential existence of biofilm-producing 
strains in food and / or food processing plants, it is a 
challenge to find substances with anti-biofilm 
activity. The plants and derived products offer a 
potential natural alternative. Some natural products 
have the ability to inhibit the formation of the 
biofilm formed as well as prevent the formation 
thereof (43). Conversely, other plants do not have 
this effect. Many of these agents have their activity 
tested in planktonic cultures. However, the activity 
on sessile forms of life, responsible for the gravest 
problems, is still understudied. Studies that evaluate 
antibiofilm activity should deal with the activity 
against consolidated biofilms and anti-adherent 
properties as a prophylactic measure against the 
formation of biofilm (44). 
   Sanchez et al, 2016 found inhibitory activity of 
biofilm against E. coli and S. aureus in a species of 
the genus Prosopis (45).  Contrary, the results 
obtained in our work determined that all tested 
natural products single showed no inhibitory activity 
in biofilm formation by Listeria. None of the 
combinations tested showed inhibitory effect of 
biofilms at least under the conditions of the assay. 
Further research is required to find an effective way 
to clean the surfaces and effective sanitization 
methods to completely remove this bacterium. 
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Table 1. The MIC and FIC values of vegetable extracts for strains of Listeria tested. 
Vegetable 
Extracts 
A 
 
B 
 
C 
 
D 
 
A+B 
 
A+C 
 
A+D 
 
B+C 
 
B+D 
 
C+D 
 
MIC 
(mg/ml) 
10 20 2.5 5.0 5.0 2.5 5.0 1.25 10 5.0 
FIC     0.75 1.25 1.5 0.56 2.5 3.0 
A: A. caven. B: A. furcatispina. C: P. torquata. D: N. cataria. MIC: minimum inhibitory concentration. 
FIC: fractional inhibitory concentration. 
Table 2. Interactions of vegetable extracts. 
Interactions Effect 
A. Caven and A. Furcatispina (A+B) (0.75)         Additive 
A. caven and P. torquata (A+ C) (1.25)         Indifferent 
A. Furcatispina and P. torquata (B+C) (0.56)         Additive 
A. caven and N. cataria (A+D) (1.50)         Indifferent 
A. furcatispina and N. cataria (B+D) (2.50)         Indifferent 
P. torquata and N. cataria (C+D) (3.00)         Indifferent 
(Number) denotes the ΣFIC index value. 
Table 3. Detection biofilm-forming strains for quantitative microplate method. 
Strain Absorbance Standard 
Deviation 
L. grayi  LG01 0.270 ± 0.027 
L. ivannovii 0.199 ± 0.050 
L. seeligeri LS01 0.222 ± 0.057 
L. monocytogenes LM01 0.340 ± 0.017 
L. monocytogenes 74910 0.131 ±0.015 
L. innocua 74915 0.219 ± 0.043 
L. innocua LI56 0.202 ± 0.050 
 
 
 
L. innocua LI02H 0.327 ± 0.027 
L. innocua LI1788 0.334 ± 0.028 
L. innocua LI1787 0.281 ± 0.012 
L. innocua  LI1792 0.186 ± 0.020 
L. innocua LI1790 0.215 ± 0.022 
L. innocua LI1791 0.175 ± 0.016 
L. innocua LI1779 
L. innocua LI1782 
0.182 
0.160 
± 0.017 
±0.014 
*L. monocytogenes CLIP 74904 0.375 ± 0.039 
*S. aureus 11F2 0.442 ± 0.074 
*S. epidermidis ATCC 12228 0.274 ± 0.012 
Control medium 0.056 ± 0.010 
Cutoff value OD550  ≥0.300 biofilm producer strain. *S. aureus 11F2 (positive control), L. monocytogenes CLIP 74904 
(positive control), S. epidermidis ATCC 12228 (negative control). 
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Figure 1. Biofilm producer strains (Cutoff value OD550 ≥0.300). 
S. aureus 11F2 (positive control), L. monocytogenes CLIP 74904 
(positive control), S. epidermidis 12228 (negative control). 
 
 
 
 
 
 
 
